Searched for
MANKIND PHARMA SHARES
Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sectorBernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...22 May, 2026, 04.40 PM IST- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...20 May, 2026, 12.05 PM IST
- Bayer bets big on 'self-care' market to deepen India playGlobal pharma major Bayer is significantly expanding its consumer healthcare presence in India, targeting the burgeoning self-care market e...20 May, 2026, 10.30 AM IST
- Is your portfolio FII-proof? 7 stocks Jefferies says can defy the $53 billion foreign selloffForeign investors have divested $53 billion from Indian equities since late 2024, leading to underperformance against emerging markets. Dom...14 May, 2026, 03.54 PM IST
- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...08 May, 2026, 12.50 PM IST
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is not every day that you see crude oil prices moving higher and the Asian markets, including India, also inching higher. Now, as an inv...27 Apr, 2026, 09.51 PM IST
- SUSE eyes deeper India push as CEO flags growth, open-source demandSUSE plans to increase investments in India, recognizing it as a significant growth market for open-source technologies. The company aims t...22 Apr, 2026, 06.00 AM IST
- Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%Usually, official talks are mere formalities – meetings to ink things that have already been agreed upon. The one scheduled between the US ...10 Apr, 2026, 10.59 PM IST
- Mankind Pharma shares jump 2% as Morgan Stanley initiates coverage with Overweight call. Check target, upsideMankind Pharma share price surged 2% after Morgan Stanley initiated coverage with an 'Overweight' rating and a Rs 2,500 target price, citin...27 Mar, 2026, 09.31 AM IST
- Mankind Pharma shares in focus after Q3 net profit rises 8%YoY to Rs 414 croreThe company reported an 8% year-on-year rise in Q3FY26 net profit to Rs 414 crore, while revenue grew 11.5% to Rs 3,567 crore, led by solid...04 Feb, 2026, 09.47 AM IST
- Mankind Pharma shares in focus after Q3 net profit drops 16% YoY to Rs 385 croreMankind Pharma's shares are in focus following a 16.5% YoY decline in Q3 net profit to Rs 385 crore, despite strong revenue growth of 24%. ...24 Jan, 2025, 09.10 AM IST
- Mankind Pharma shares gain over 6% as profit jumps nearly 30% in Q2Mankind Pharma's shares surged by 6% after reporting a 29% rise in Q2 profits, reaching ₹658.88 crore. The company attributed this growth t...06 Nov, 2024, 10.11 AM IST
- Mankind Pharma shares drop 2% despite 10% YoY Q1 PAT growth. Buy, sell, or hold?Mankind Pharma's shares fell 2% to Rs 1,985.50, despite the company announcing a 10% YoY rise in net profit to Rs 543 crore for the first q...01 Aug, 2024, 02.12 PM IST
- Mankind Pharma shares fall 2.5% after BSV acquisitionMankind Pharma Share Price: Mankind Pharma shares dropped by 2.5% following the announcement of a Rs 13,630 crore acquisition of Bharat Ser...26 Jul, 2024, 11.45 AM IST
- Mankind Pharma shares jump 9% post Q1 earnings. Should you buy?The domestic business reported a robust 14% YoY growth in the quarter. The secondary sales saw an impressive growth of 12.5%, thereby outpe...03 Aug, 2023, 10.56 AM IST
- Mankind Pharma shares plunge over 5% as I-T department raids Delhi officeShares of Mankind Pharma dropped 5.5% following news of India's income tax department conducting searches at its Delhi office. Its shares a...11 May, 2023, 11.11 AM IST
- Mankind Pharma shares tank over 6% a day after solid debut. Time to buy?Shares of Mankind Pharma fell more than 6%, a day after its listing on the Indian stock exchanges at a premium. The company's IPO was the l...10 May, 2023, 11.27 AM IST
Load More
